- 专利标题： Long-term efficacy of liver disease treatment with EPA and DHA
-
申请号： US16483730申请日： 2018-02-06
-
公开(公告)号： US20200022941A1公开(公告)日： 2020-01-23
- 发明人: Martin Westphal , Silke Baasner , Stefanie HONNDORF , Edmundo BRITO DE LA FUENTE , Crispulo Gallegos-Montes , Lida Quinchia-Bustamante
- 申请人： Fresenius Kabi Deutschland GmbH
- 优先权： EP17155032.0 20170207
- 国际申请： PCT/EP2018/052873 WO 20180206
- 主分类号： A61K31/202
- IPC分类号： A61K31/202 ; A61P1/16 ; A61K9/00 ; A61K47/24 ; A61K47/12 ; A61K47/10
摘要：
The present invention relates to the treatment of liver diseases. In particular, it relates to a composition for use in treating and/or preventing a liver disease in a subject, wherein said composition comprises eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) wherein the ratio of EPA to DHA is at least 2:1.
信息查询
IPC分类:
